Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The voltage-dependent L-type calcium channel subunit alpha-1F is the pore-forming alpha-1 subunit of the Cav1.4 channel encoded by the CACNA1F gene[4][1]. It is predominantly expressed in the retina within photoreceptor synaptic terminals, where it plays a crucial role in visual signal transmission by mediating sustained calcium influx in response to membrane depolarization[4]. As part of the high voltage-activated (HVA) L-type calcium channel family, alpha-1F forms heteromultimeric complexes with auxiliary subunits (alpha-2/delta, beta, and sometimes gamma)[1][3]. The alpha-1F subunit is essential for enabling calcium-dependent processes linked to neurotransmitter release, with distinct features compared to other L-type channel isoforms (such as Cav1.2 and Cav1.3). Mutations in CACNA1F cause congenital stationary night blindness type 2A (CSNB2A) and other X-linked visual disorders[4]. L-type channels, including alpha-1F, are generally sensitive to dihydropyridine calcium antagonists, though alpha-1F selectivity is limited among current drugs[4][1]. Broader L-type channel inhibition affects muscle, endocrine, and neuronal function, contributing to safety concerns for systemic therapies.
Blockade of L-type calcium channels, inhibiting calcium influx and reducing downstream calcium-dependent signaling (for drugs in the L-type blocker class) Modulation of neurotransmitter/hormone release, muscle contraction, and gene expression via alteration of membrane calcium entry
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Voltage-dependent L-type calcium channel subunit alpha-1F.